{
  "docId": "019de071-b6aa-745b-9366-85da01204b7f",
  "docSlug": "36e600bcc4f8cdbd41dc817cb6eec90e",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 91 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 49,
  "pageCount": 91,
  "prevPage": 48,
  "nextPage": 50,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 60,
  "notes": "Includes detailed footnotes regarding non-GAAP adjustments and constant currency calculations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-b6aa-745b-9366-85da01204b7f/49",
  "deckHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f",
  "deckJsonHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f.json",
  "deckAnchorHref": "/decks/019de071-b6aa-745b-9366-85da01204b7f#slide-49",
  "components": [
    {
      "bbox": {
        "h": 0.075,
        "w": 0.725,
        "x": 0.258,
        "y": 0.915
      },
      "kind": "source-note",
      "text": "1. See Slide 2 and Appendix for further non-GAAP information. 2. See Appendix for further information on the use and calculation of constant currency. 3. Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 4. See Appendix for details on amortization and impairments of intangible assets. 5. This figure includes the dilutive impact of options and restricted stock units of approximately 5,221, 000 and 3,144,000 and common shares for the nine months ended September 30, 2021 and 2020 which are excluded when calculating GAAP diluted loss per share because the effect of including the impact in this calculation would have been anti-dilutive. 6. Excludes legacy legal settlements (net of insurance recoveries), separation payments, separation-related payments, IPO payments and IPO-related payments and net cash provided by Amoun operating activities. In 3Q21, the adjustment resulted in a decrease to Adjusted Cash from Operations in 3Q21, due to these insurance recoveries.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e06805e-b9da-4ac6-9a59-922e10f1443b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.735,
        "w": 0.966,
        "x": 0.017,
        "y": 0.155
      },
      "kind": "table",
      "text": "Financial performance table comparing 9.30.21 vs 9.30.20 across Revenues, Net Loss, Adj. Net Income, EPS, Cash Flows, Gross Profit, Margin, A&P, G&A, R&D, Operating Expense, EBITA, and EBITDA.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f6bbfef-2062-4cb7-9782-12d4b09988ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.365,
        "x": 0.201,
        "y": 0.075
      },
      "kind": "title",
      "text": "Financial Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76745f79-317a-446e-a1d0-c65fe881c8ca",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "567d03ab-ff8f-4c70-8e09-5beb59bbed02",
      "evidence": "Financial performance table comparing 9.30.21 vs 9.30.20 across Revenues, Net Loss, Adj. Net Income, EPS, Cash Flows, Gross Profit, Margin, A&P, G&A, R&D, Operating Expense, EBITA, and EBITDA.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 91,
      "from": 29,
      "beatId": "0780a7c7-2762-4aae-8cf5-fadf057913bf",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The document concludes with a call to action and appendix data",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}